B.Braun LogoB.Braun Logo
      • Strona główna
      • Leki dożylne
      • Leki znieczulające i uspokajające

      • Propofol-®Lipuro 20 mg/ml

      Propofol-®Lipuro 20 mg/ml-Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 d<br/>ays.
      Propofol-®Lipuro 20 mg/ml-Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 d<br/>ays.
      Propofol-®Lipuro 20 mg/ml-Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 d<br/>ays.
      Propofol-®Lipuro 20 mg/ml-Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 d<br/>ays.
      Propofol-®Lipuro 20 mg/ml-Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 d<br/>ays.

      Propofol-®Lipuro 20 mg/ml
      Emulsion for injection or infusion. The Propofol for patients requiring long-term sedation for up to 7 days.

      Propofol-®Lipuro 20 mg/ml is a short-acting intravenous general anaesthetic for

      • Induction and maintenance of general anaesthesia in adults and children > 3 years
      • Sedation of ventilated patients >16 years of age in the intensive care unit
      • Sedation for diagnostic and surgical procedures, alone or in combination with local or regional anaesthesia in adults and children > 3 years
      • Induction of sedation for diagnostic and surgical procedures

      Available in infusion bottle 50 ml 
       

      Czytaj więcej

      Referencje

      1. Müller RH, Harnisch S. Physico chemical characterization of propofol-loaded emulsions and interaction with plasma proteins. Eur Hosp Pharm 2000; 6: 24-31.
      2. Larsen B, Beerhalter U, et al. Less pain on injection by a new formulation of propofol? A comparison with propofol LCT. Anaesthesist 2001; 50(11): 842-5.
      3. Rau J, Roizen MF, et al. Propofol in an emulsion of long- and medium-chain triglycerides: the effect on pain. Anesth Analg 2001; 93(2): 382-4.
      4. Marsili I, Iovinelli G, et al. Parenteral nutrition in COPD patients: long vs. mediumchain triglycerides (MCT). Clinical Nutrition 1992; 11: 45, special supplement.
      5. Waitzberg DL, Bellinati-Pires R, et al. Eff ect of total parenteral nutrition with diff erent lipid emulsions on human monocyte and neutrophil funcions. Nutrition 1997; 13: 128-132.
      6. Carpentier YA, Siderova V, et al. Long-term TPN and liver dysfunction. Clinical Nutrition 1989; 8: 31, special supplement.